Discovery of small molecule modulators of the thin filament that alter the contractile profile in a hypertrophic cardiomyopathy engineered tissue model
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2025.110938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Ruth F Sommese und 22 weiteren Autor:innen. Beteiligte Einrichtung: Medicine Design, Pfizer Inc, Groton, Connecticut, USA. Electronic address: Ruth.Sommese@pfizer.com. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Myocardial Contraction, Small Molecule Libraries, Tissue Engineering. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Illinois at Chicago.
Abstract (Originalsprache)
Underlying both cardiomyopathies and heart failure is the alteration of the contractile profile of the myocardium leading to impairments in force generation (i.e., systolic function) or relaxation kinetics (i.e., diastolic function) of the sarcomere. Fundamental studies of the sarcomeric unit of striated muscle as well as significant genetic evidence from hereditary cardiomyopathies have implicated the thin filament complex as a key multi-protein complex tightly regulating contraction and relaxation kinetics in cardiac muscle. Utilizing affinity selection mass spectrometry high-throughput screening, we set out to identify small-molecules that bind to the cardiac thin filament and result in calcium desensitization in reconstituted biochemical and tissue-isolated myofibril systems. Through chemical optimization to improve potency and solubility, we further developed a series and were able to confirm target engagement with intact reconstituted cardiac thin filaments using isothermal calorimetry. Optimization of several absorption, distribution, metabolism, and excretion properties provided exemplar compounds that in matrixed tension assays using mouse skinned fibers showed diverse antagonist and desensitization profiles. Two of these compounds with mixed desensitization-antagonist profiles were further tested in an engineered heart tissue model of hypertrophic cardiomyopathy and were confirmed to demonstrate mixed pharmacology with impacts on max force contraction and relaxation kinetics from the contracted to relaxed state. Together these studies provide a starting point for future efforts to develop selective, thin filament-targeted small molecules that potentially provide a new mechanism for treatment of heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicine Design, Pfizer Inc, Groton, Connecticut, USA. Electronic address: Ruth.Sommese@pfizer.com.
- Medicine Design, Pfizer Inc, Cambridge, Massachusetts, USA.
- Medicine Design, Pfizer Inc, Groton, Connecticut, USA.
- Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA.
- Nonclinical Statistics, Pfizer Inc, Cambridge, Massachusetts, USA.
Förderung
- University of Illinois at Chicago
Zitieren
APA
Sommese, R. F., Levi, S. M., Brown, J., Polivkova, J., Byrnes, L. J., Kue, R., Damilano, F., Hua, W., Boehm, M., Dushin, E., Filipski, K. J., Kormos, B. L., Li, Q., Miller, R., Ogilvie, K., Ridgway, N., Smith, A. C., Stansfield, J. C., Wang, Y., …, & Ward, J. (2026). Discovery of small molecule modulators of the thin filament that alter the contractile profile in a hypertrophic cardiomyopathy engineered tissue model. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110938
Vancouver
Sommese RF, Levi SM, Brown J, Polivkova J, Byrnes LJ, Kue R, et al. Discovery of small molecule modulators of the thin filament that alter the contractile profile in a hypertrophic cardiomyopathy engineered tissue model. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.110938
BibTeX
@article{Sommese2026,
author = {Sommese, Ruth F and Levi, Samuel M and Brown, Janice and Polivkova, Jana and Byrnes, Laura J and Kue, Richard and Damilano, Federico and Hua, Wenyi and Boehm, Markus and Dushin, Elizabeth and Filipski, Kevin J and Kormos, Bethany L and Li, Qifang and Miller, Russell and Ogilvie, Kevin and Ridgway, Noelle and Smith, Aaron C and Stansfield, John C and Wang, Yang and Withka, Jane and Zhang, Hui and Griffith, David A and Ward, Jessica},
title = {Discovery of small molecule modulators of the thin filament that alter the contractile profile in a hypertrophic cardiomyopathy engineered tissue model},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2025.110938}
}
EUVIMED